The gut microbiota profile in psoriasis: a Brazilian case-control study
Abstract
The pathogenesis of psoriasis, an immune-mediated chronic inflammatory skin disease, remains unclear. Studies have shown an association between psoriasis and intestinal inflammation; in this context, the influence of the gut microbiota on the immune response of psoriasis has become a focus of recent research. The present research evaluated the composition and diversity of the gut microbiota of 21 participants with psoriasis from a Brazilian referral dermatology service compared to 24 healthy controls. A stool sample was collected from each participant at the time of inclusion in the study, and the samples were analysed by sequencing the 16S rRNA gene. The recruitment of research participants involved matching between groups by sex, age, body mass index, comorbidities and smoking and the exclusion of several criteria that could potentially influence the gut microbiota and the interpretation of the data. There was an increase in the Dialister genus and Prevotella copri species in patients with psoriasis compared to the control group. A reduction in the Ruminococcus, Lachnospira and Blautia genera, as well as in the Akkermansia muciniphila species, was also verified in the psoriasis group compared to the control group. Furthermore, patients with psoriasis exhibited less gut microbiota diversity than controls.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Probiotics have been investigated for their ability to alleviate irritable bowel syndrome (IBS) symptoms, and certain probiotic strains like Bifidobacterium infantis and Lactobacillus plantarum can reduce inflammation and restore gut barrier function in IBS patients.
“Bloating, stomach discomfort, and constipation are all signs of irritable bowel syndrome (IBS), and probiotics have been investigated for their ability to alleviate these conditions. Inflammation can be reduced and gut barrier function can be restored in IBS patients by taking certain probiotic strains like Bifidobacterium infantis and Lactobacillus plantarum.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
SCFAs might boost the production of anti-inflammatory cytokines like interleukin-10 (IL-10) and encourage the formation of regulatory T cells (Tregs), resulting in a more normal immune response, which decreases inflammation and protects against autoimmune diseases.
“SCFAs, for instance, might boost the production of anti-inflammatory cytokines like interleukin-10 (IL-10) and encourage the formation of regulatory T cells (Tregs). This results in a more normal immune response, which in turn decreases inflammation and protects against autoimmune diseases.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Postbiotics can help the immune system learn to distinguish between innocuous and hazardous chemicals (immunological tolerance), preventing inappropriate immune responses to innocuous antigens and allergens by instructing the immune system and encouraging the growth of regulatory immune cells.
“Postbiotics can help the immune system learn to distinguish between innocuous and hazardous chemicals, a process known as immunological tolerance. Postbiotics aid in preventing inappropriate immune responses to innocuous antigens and allergens by instructing the immune system and encouraging the growth of regulatory immune cells.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Both probiotics and postbiotics have demonstrated positive results in the treatment of inflammatory bowel disease (IBD), and disease severity and remission rates in people with ulcerative colitis and Crohn's disease have been linked to the use of certain probiotics, such as Saccharomyces boulardii and Bifidobacterium breve.
“Both probiotics and postbiotics have demonstrated positive results in the treatment of inflammatory bowel disease (IBD). Disease severity and remission rates in people with ulcerative colitis and Crohn’s disease have been linked to the use of certain probiotics, such as Saccharomyces boulardii and Bifidobacterium breve.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
The anti-inflammatory effects of postbiotics, especially short-chain fatty acids, are important in the regulation of inflammatory bowel disease (IBD) symptoms.
“The anti-inflammatory effects of postbiotics, especially short-chain fatty acids, are important in the regulation of inflammatory bowel disease (IBD) symptoms.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Some postbiotics, such as bacteriocins and organic acids, have antibacterial capabilities that can impede the development and spread of dangerous pathogenic microorganisms in the digestive tract, reducing harmful microbes and protecting against infections.
“Some postbiotics, such as bacteriocins and organic acids, have antibacterial capabilities that can impede the development and spread of dangerous pathogenic microorganisms in the digestive tract.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Postbiotics like short-chain fatty acids (SCFAs) and exopolysaccharides (EPS) can provide food for beneficial bacteria such as Lactobacilli and Bifidobacteria, boosting their development and activity, increasing their dominance, diversity and stability of the microbiome.
“Postbiotics like short-chain fatty acids (SCFAs) and exopolysaccharides (EPS) can provide food for beneficial bacteria.In the gut, such as Lactobacilli and Bifidobacterial.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Many postbiotics, including short-chain fatty acids (SCFAs) and peptidoglycans, have anti-inflammatory effects by regulating the activity of inflammatory immune cells and reducing the production of inflammatory cytokines, which is critical for protecting against chronic inflammation and keeping the gut in good working order.
“Many postbiotics, including short-chain fatty acids (SCFAs) and peptidoglycans, have anti-inflammatory effects. They can regulate the activity of inflammatory immune cells and reduce the production of inflammatory cytokines. This anti-inflammatory impact is critical for protecting against chronic inflammation and keeping the gut in good working order.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Evidence is mounting that probiotics and prebiotics may be useful in controlling autoimmune illnesses including rheumatoid arthritis and multiple sclerosis by altering the composition of the gut flora, affecting immunological dysregulation and potentially reducing autoimmune reactions.
“Evidence is mounting that probiotics and prebiotics may be useful in controlling autoimmune illnesses including rheumatoid arthritis and multiple sclerosis by altering the composition of the gut flora. These bioactive compounds affect immunological dysregulation and might reduce autoimmune reactions.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Probiotics and prebiotics can mitigate allergy diseases including eczema and rhinitis by regulating the balance between Th1 and Th2 immune responses.
“It has been investigated whether or not probiotics and prebiotics can mitigate allergy diseases including eczema and rhinitis. They are essential in the regulation of the balance between Th1 and Th2 immune responses, which are responsible for the development of allergic disorders.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Weight loss and enhancement of metabolic indicators in obese people have been linked to the use of probiotics such as Lactobacillus rhamnosus and Bifidobacterium lactis.
“Weight loss and enhancement of metabolic indicators in obese people have also been linked to the use of probiotics such as Lactobacillus rhamnosus and Bifidobacterium lactis.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Probiotics and prebiotics improve glucose metabolism and decrease inflammation in diabetes patients by altering the makeup and function of the gut microbiota.
“Glycemic management and insulin sensitivity in people with type 2 diabetes have been studied as a possible benefit of probiotics and prebiotics. These bioactive compounds improve glucose metabolism and decrease inflammation in diabetes patients by altering the makeup and function of the gut microbiota.”
From Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony (2024) · cites this paper as [29]
Cites
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · see citing works
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. E. (2011) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 14,484 · see citing works
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · see citing works
STAMP: statistical analysis of taxonomic and functional profiles
Parks, D. H., Tyson, G. W., Hugenholtz, P., & Beiko, R. G. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu494 · Cited by 4,200 · see citing works
The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks
Yilmaz, P., Parfrey, L., Yarza, P., Gerken, J., Pruesse, E., Quast, C., Schweer, T., Peplies, J., Ludwig, W., & Glöckner, F. (2013) · Nucleic Acids Res. · doi:10.1093/nar/gkt1209 · Cited by 3,547 · see citing works
The role of the gut microbiota in nutrition and health
Flint, H. J., Scott, K. P., Louis, P., & Duncan, S. H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.156 · Cited by 2,203 · see citing works
Best practices for analysing microbiomes
Knight, R., Vrbanac, A., Taylor, B. C., Aksenov, A., Callewaert, C., Debelius, J., Gonzalez, A., Kosciolek, T., McCall, L.-I., McDonald, D., et al. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0029-9 · Cited by 2,030 · see citing works
Blautia —a new functional genus with potential probiotic properties?
Liu, X., Mao, B., Gu, J., Wu, J., Cui, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1875796 · Cited by 1,398 · see citing works
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 931 · see citing works
Scher, J. U., Úbeda, C., Artacho, A., Attur, M. G., Isaac, S., Reddy, S. M., Marmon, S., Neimann, A. L., Brusca, S. B., Patel, T., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38892 · Cited by 820 · see citing works
Goodrich, J. K., Di Rienzi, S. C., Poole, A. C., Koren, O., Walters, W. A., Caporaso, J. G., Knight, R., & Ley, R. E. (2014) · Cell · doi:10.1016/j.cell.2014.06.037 · Cited by 714 · see citing works
The gut microbiome as a major regulator of the gut-skin axis
Salem, I., Ramser, A., Isham, N., & Ghannoum, M. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01459 · Cited by 707 · see citing works
Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M., & Salminen, S. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01477-07 · Cited by 706 · see citing works
Sample storage conditions significantly influence faecal microbiome profiles
Choo, J. M., Leong, L. E. X., & Rogers, G. B. (2015) · Scientific Reports · doi:10.1038/srep16350 · Cited by 506 · see citing works
Illumina-based analysis of microbial community diversity
Degnan, P. H., & Ochman, H. (2011) · The ISME Journal · doi:10.1038/ismej.2011.74 · Cited by 421 · see citing works
Role of the gut microbiota in defining human health
Fujimura, K. E., Slusher, N. A., Cabana, M. D., & Lynch, S. V. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.14 · Cited by 408 · see citing works
Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis
Tito, R. Y., Cypers, H., Joossens, M., Varkas, G., Praet, L. V., Glorieus, E., den Bosch, F. E. V., Vos, M. D., Raes, J., & Elewaut, D. S. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39802 · Cited by 277 · see citing works
Gut microbiota dysbiosis in a cohort of patients with psoriasis
Hidalgo‐Cantabrana, C., Gómez, J., Delgado, S., Requena‐López, S., Queiro‐Silva, R., Margolles, A., Coto, E., Sánchez, B., & Coto‐Segura, P. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17931 · Cited by 236 · see citing works
Critical role of environmental factors in the pathogenesis of psoriasis
Zeng, J., Luo, S., Huang, Y., & Lu, Q. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13806 · Cited by 229 · see citing works
Gut microbial composition in patients with psoriasis
Codoñer, F. M., Ramírez-Boscá, A., Climent, E., Carrión-Gutiérrez, M. A., Guerrero, M., Pérez-Orquín, J. M., de la Parte, J. H., Genovés, S., Ramón, D., Navarro‐López, V., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22125-y · Cited by 211 · see citing works
The Akkermansia muciniphila is a gut microbiota signature in psoriasis
Tan, L., Zhao, S., Zhu, W., Wu, L., Li, J., Shen, M., Li, L., Chen, X., & Peng, C. (2017) · Experimental Dermatology · doi:10.1111/exd.13463 · Cited by 189 · see citing works
Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls
Shapiro, J., Cohen, N., Shalev, V., Uzan, A., Koren, O., & Maharshak, N. (2019) · Journal of dermatology (Print) · doi:10.1111/1346-8138.14933 · Cited by 141 · see citing works
Scarpa, R., Manguso, F., D'Arienzo, A., D’Armiento, F. P., Astarita, C., Mazzacca, G., & Ayala, F. (2000) · PubMed · Cited by 141 · see citing works
The role of the skin and gut microbiome in psoriatic disease
Yan, D., Issa, N., Afifi, L., Jeon, C., Chang, H.-W., & Liao, W. (2017) · Current Dermatology Reports · doi:10.1007/s13671-017-0178-5 · Cited by 135 · see citing works
The gut microbiome in psoriasis and psoriatic arthritis
Myers, B., Brownstone, N., Reddy, V., Chan, S., Thibodeaux, Q., Truong, A., Bhutani, T., Chang, H.-W., & Liao, W. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101494 · Cited by 127 · cited 2× · see citing works
“Increasing evidence indicates that changes in the cutaneous and gut microbiota (dysbiosis) may induce activation of the Th17 pathway, leading to the development of psoriasis (Yan et al. 2017; Myers et al. 2019).”
BackgroundIntestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients
Chen, Y.-J., Ho, H., Tseng, C., Lai, Z., Shieh, J., & Wu, C.-Y. (2018) · Experimental Dermatology · doi:10.1111/exd.13786 · Cited by 118 · see citing works
Human Microbiome: Composition and Role in Inflammatory Skin Diseases
Balato, A., Cacciapuoti, S., Caprio, R. D., Marasca, C., Masarà, A., Raimondo, A., & Fabbrocini, G. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0528-4 · Cited by 110 · see citing works
Association of dietary fibre intake and gut microbiota in adults
Lin, D., Peters, B. A., Friedlander, C., Freiman, H. J., Goedert, J. J., Sinha, R., Miller, G., Bernstein, M. A., Hayes, R. B., & Ahn, J. (2018) · British Journal of Nutrition · doi:10.1017/s0007114518002465 · Cited by 109 · see citing works
Dysbiosis of gut microbiota was closely associated with psoriasis
Huang, L., Gao, R., Yu, N., Zhu, Y., Ding, Y., & Qin, H. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9376-6 · Cited by 98 · see citing works
Gut bacterial microbiota in psoriasis: A case control study
Doaa, M., Dalia, M., & Ahmed, F. S. (2016) · African Journal of Microbiology Research · doi:10.5897/ajmr2016.8046 · Cited by 56 · see citing works
Psoriasis Is Associated With Elevated Gut IL-1α and Intestinal Microbiome Alterations
Yegorov, S., Babenko, D., Kozhakhmetov, S., Akhmaltdinova, L., Kadyrova, I., Nurgozhina, A., Nurgaziyev, M., Good, S. V., Hortelano, G., Yermekbayeva, B., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571319 · Cited by 47 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Role of gut microbiota in infectious and inflammatory diseases
Maciel-Fiuza, M. F., Müller, G. C., Campos, D. M. S., Costa, P. D. S. S., Peruzzo, J., Bonamigo, R. R., Veit, T. D., & Vianna, F. S. L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1098386 · Cited by 253 · see citing works
Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony
Zhou, P., Chen, C., Patil, S., & Dong, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1355542 · Cited by 193 · see citing works
Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases
Effendi, R. M. R. A., Anshory, M., Kalim, H., Dwiyana, R. F., Suwarsa, O., Pardo, L. M., Nijsten, T. E. C., & Thio, H. B. (2022) · Microorganisms · doi:10.3390/microorganisms10122382 · Cited by 190 · see citing works
Buhaș, M. C., Gavrilaș, L. I., CANDREA, A. R., Cătinean, A., Mocan, A., Miere, D., & Tataru, A. D. (2022) · Nutrients · doi:10.3390/nu14142970 · Cited by 130 · see citing works
Transforming Psoriasis Care: Probiotics and Prebiotics as Novel Therapeutic Approaches
Buhaș, M. C., CANDREA, A. R., Gavrilaș, L. I., Miere, D., Tataru, A. D., Boca, A., & Cătinean, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311225 · Cited by 98 · see citing works
Tie, Y., Huang, Y., Chen, R., Li, L., Chen, M., & Zhang, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2265028 · Cited by 92 · see citing works
Beneficial Effects of Plant-Based Diets on Skin Health and Inflammatory Skin Diseases
Flores-Balderas, X., Peña-Peña, M., Rada, K. M., Alvarez-Alvarez, Y. Q., Guzmán-Martín, C. A., Sánchez-Gloria, J. L., Huang, F., Ruiz-Ojeda, D., Morán‐Ramos, S., Springall, R., et al. (2023) · Nutrients · doi:10.3390/nu15132842 · Cited by 58 · see citing works
Role of Intestinal Dysbiosis and Nutrition in Rheumatoid Arthritis
Attur, M., Scher, J. U., Abramson, S. B., & Attur, M. G. (2022) · Cells · doi:10.3390/cells11152436 · Cited by 49 · see citing works
The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
Ryguła, I., Pikiewicz, W., Grabarek, B. O., Wójcik, M., & Kaminiów, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041984 · Cited by 46 · see citing works
Health and Disease:Akkermansia muciniphila, the Shining Star of the Gut Flora
Xue, C., Li, G., Gu, X., Su, Y., Zheng, Q., Yuan, X. H., Bao, Z., Lu, J., & Li, L. (2023) · Research · doi:10.34133/research.0107 · Cited by 43 · see citing works
Causal Associations Between Gut Microbiota and Psoriasis: A Mendelian Randomization Study
Zang, C., Liu, J., Mao, M., Zhu, W., Chen, W., & Wei, B. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-01007-w · Cited by 30 · see citing works
Han, E. J., Ahn, J., Chae, Y. J., & Chung, H. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09093-8 · Cited by 27 · see citing works
The role of diet in the management of psoriasis: a scoping review
Hawkins, P., Earl, K., Tektonidis, T. G., & Fallaize, R. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000185 · Cited by 26 · see citing works
Radaschin, D. S., Tatu, A. L., Iancu, A. V., Beiu, C., & Popa, L. G. (2024) · Medicina · doi:10.3390/medicina60101619 · Cited by 24 · see citing works
Alterations of gut microbiota for the onset and treatment of psoriasis: A systematic review
Xue, M., Deng, Q., Deng, L., Xun, T., Huang, T., Zhao, J., Wei, S., Zhao, C., Chen, X., Zhou, Y., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177521 · Cited by 24 · see citing works
Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculeț, E., Bujoreanu, F. C., Beiu, C., Tatu, A. L., & Popa, L. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910583 · Cited by 17 · see citing works
Characterization of the Gut Microbiota in Patients with Psoriasis: A Systematic Review
Gao, Y., Lou, Y., Hui, Y., Chen, H., Sang, H., & Liu, F. (2025) · Pathogens · doi:10.3390/pathogens14040358 · Cited by 16 · see citing works
Psoriasis and gut microbes: research advances from mechanism to therapy
Chen, J., Sun, K., Zhang, X., Chen, X., Chu, Y., Geng, L., Bian, Z., Su, Y., Cong, X., & Wang, G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1711288 · Cited by 16 · see citing works
New horizons in the treatment of psoriasis: Modulation of gut microbiome
Memariani, M., & Memariani, H. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41672 · Cited by 14 · see citing works
The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients
Kranyak, A. C., Haran, K., Smith, P. L., Johnson, C. E., Liao, W. J., & Bhutani, T. (2024) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/24755303241226626 · Cited by 10 · see citing works
Insights into the gut microbiome of vitiligo patients from India
Kumar, S., Mahajan, S., Kale, D., Chourasia, N., Khan, A., Asati, D. P., Kotnis, A. L., & Sharma, V. K. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03529-5 · Cited by 10 · see citing works
Wang, Y.-W., Yao, T., Lin, Y., Ge, H., Huang, B., Gao, Y., & Wu, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1327083 · Cited by 8 · see citing works
Therapeutic potential of microbiota modulation in psoriasis: current evidence and future directions
Bakhshandi, A. K., Minasazi, A., Yeganeh, O., & Behi, M. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04097-y · Cited by 6 · see citing works
Vižlin, A., Björkman, Y. A., Kumar, Y., Göthe, M., Gillstedt, M., & Osmančević, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147745 · Cited by 3 · see citing works
Polo, T. C. F., Lai, M. R. D. R., Miot, L. D. B., Bento, G. F. C., da Silva, M. G., Marques, S. A., & Miot, H. A. (2023) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2022.08.008 · Cited by 3 · see citing works
Association between psoriasis and gut microbiota: a review
Vasilyeva, V. P., Yenina, D. S., Kapustina, E., Kapko, A. V., Cherkasova, A. A., & Raevskii, K. P. (2025) · Russian Medicine · doi:10.17816/medjrf643065 · Cited by 2 · see citing works
Lai, Y., Jiang, Z., Qiu, X., Hong, D., Liu, X., Liu, S., Wu, X., Guo, S., Bloomstein, J. D., Hwang, S. T., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.08.017 · Cited by 2 · see citing works
Luo, M., Gao, J., Zhang, Y., Long, D., Pan, Y., Yan, Y., Zhou, R., Jiang, M., Wang, B., Chen, Y., et al. (2026) · Experimental Dermatology · doi:10.1111/exd.70317 · Cited by 2 · see citing works
Evaluating the role of the gut microbiota in autoimmune skin diseases: A scoping review
Agarwal, P., Wolfe, S. M., Sanabria, B., Pathak, G. N., Alamgir, M., & Rao, B. K. (2024) · JAAD reviews. · doi:10.1016/j.jdrv.2024.09.002 · Cited by 2 · see citing works
Probiotics is riding high: effects of gut microbiota on skin health
Song, Z., Song, R., Lan, L., Cheng, K., & Zhang, X. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250467 · Cited by 1 · see citing works
Exploring the Gut Microbiome’s Association in Psoriasis and Psoriatic Arthritis: A Scoping Review
Kent, J., Chao, J., Liao, W. J., & Singla, S. (2026) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/24755303261464171 · Cited by 1 · see citing works
Pharmacomicrobiomics in inflammatory skin diseases: past, present, and the future
Khang, J., Martinez, R., Brag, K., & McGee, J. S. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1745985 · Cited by 1 · see citing works
Gut Microbiome as a Novel Treatment Strategy for Psoriasis
Zając, M., Borowiecka, M., Gruca, D., Buksak, D., & Wróblewski, W. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.09.046
Jin, Q., Ren, F., Dai, D., Zhao, Y., Li, J., Qian, Y., & Song, P. (2023) · Research Square · doi:10.21203/rs.3.rs-2767646/v1
Intake of Probiotic and Prebiotic Foods in Psoriasis Patients: A Case-Control Study in Romania
Buhaș, M. C., CANDREA, A. R., Tataru, A. D., Boboia, A., Boca, A. N., Miere, D., & Gavrilaș, L. I. (2023) · Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Food Science and Technology · doi:10.15835/buasvmcn-fst:2022.0026
The Role of Gut Microbiota in Psoriasis: Current Knowledge and Emerging Therapeutic Interventions
Memariani, H., & Memariani, M. (2024) · International Journal of Enteric Pathogens · doi:10.34172/ijep.5636
Huang, Z., Lin, J., Ding, Q., Li, X., Lin, L., & Lu, T. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03614-9
A Review and Update: The Impact of Diet and Supplements on Atopic Dermatitis
Kranyak, A. C., Leung, A., Marquez-Grap, G., & Liao, W. J. (2025) · Dermatitis · doi:10.1089/derm.2025.0063
Biotics: The Food Ingredients Supporting the Intestinal Microbiota and Immune System in Psoriasis
Biasi, J. D., Giménez‐Bastida, J. A., & Krupa‐Kozak, U. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuaf252
Xerfan, E. M. S., Souza, M. R., Rosa, D. S., Tufik, S. E. R., & Andersen, M. L. (2026) · Comprehensive physiology · doi:10.1002/cph4.70219
Gut microbiota–host immunity crosstalk in psoriasis: from dysbiosis to cutaneous inflammation
Zhang, M., Zhang, S., & Ren, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1957850
- Authors
- Schade, L., Mesa, D., Faria, A. R., Santamaria, J. R., Xavier, C. A., Ribeiro, D., Hajar, F. N., & Azevedo, V. F.
- Affiliations
- Universidade Federal do Paraná (BR)
- Instituto de Pesquisa Pelé Pequeno Príncipe Curitiba-Paraná Brazil
- Pontifícia Universidade Católica do Paraná (BR)
- Department of Internal Medicine Federal University of Paraná Curitiba Brazil
- Corresponding author
- Schade, L.
- Venue
- Letters in Applied Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-04-01
- Volume
- 74
- Issue
- 4
- Pages
- 498-504
- ISSN
- 0266-8254 (ISSN-L)
- 1472-765X
- OpenAlex
- W4200194357
- Cited by
- 42
- References
- 31
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 11 · 2023: 11 · 2022: 4
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Letters in Applied Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sociedade Brasileira de Reumatologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- psoriasis, gut microbiota, intestinal inflammation, microbial diversity, Dialister, Prevotella copri, Ruminococcus, Lachnospira, Blautia, Akkermansia muciniphila, 16S rRNA gene sequencing, immune response
- MeSH terms
- Gastrointestinal Microbiome, Humans, Psoriasis, RNA, Ribosomal, 16S, Case-Control Studies, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
